Beaming Success: Tissue Engineering Market Analysis Predicts a Thriving Sector Valued at $6,815 million by 2027
The global tissue engineering market was valued at $2,374 million in 2019, and is projected to reach $6,815 million by 2027, registering a CAGR of 14.2%
PORTLAND, OR, UNITED STATES, May 31, 2023/EINPresswire.com/ -- The Tissue engineering market refers to the development and commercialization of techniques and products aimed at replacing or repairing damaged tissues in the human body. This field of research combines principles from engineering, materials science, biology, and medicine to create functional tissues that can be implanted in the body to replace or restore the function of damaged organs or tissues.
The tissue engineering market has been growing rapidly in recent years, driven by an increasing demand for organ replacement therapies, advancements in stem cell research, and the development of new biomaterials. The global tissue engineering market was valued at $2,374 million in 2019, and is projected to reach $6,815 million by 2027, registering a CAGR of 14.2% from 2020 to 2027.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ญ: https://www.alliedmarketresearch.com/request-sample/4323
Some of the key factors driving the growth of the tissue engineering market include the rising prevalence of chronic diseases, such as cardiovascular diseases and diabetes, an aging population, and the growing demand for regenerative medicine solutions. In addition, advancements in bioprinting technology and the development of 3D bioprinters are also expected to drive growth in the market, as these technologies enable the creation of complex tissue structures with high precision.
Key players in the tissue engineering market includeAbbVie Inc. (Allergen Plc.), B. Braun Melsungen AG, Becton, Dickinson and Company (C. R. BARD, INC.), Integra LifeSciences, Organogenesis Holdings, among others. These companies are focused on developing innovative tissue engineering solutions, such as skin substitutes, bone grafts, and cartilage replacements, among others, to meet the growing demand for regenerative medicine solutions.
Rise in need for tissue engineering in organ transplantation, surge in prevalence of chronic diseases and trauma emergencies, and advancements in medical equipment technologies drive the growth of the global tissue engineering market. However, high cost associated with tissue engineered products hampers the market growth. On the contrary, untapped opportunities in the developing markets is expected to create lucrative opportunities in the future.
๐๐ก๐๐ญ ๐ข๐ฌ ๐ญ๐ก๐ ๐๐ฆ๐ฉ๐๐๐ญ ๐จ๐ ๐๐จ๐ฏ๐ข๐-๐๐ ๐๐๐ง๐๐๐ฆ๐ข๐ ๐จ๐ง ๐๐ข๐ฌ๐ฌ๐ฎ๐ ๐๐ง๐ ๐ข๐ง๐๐๐ซ๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ฅ๐จ๐๐๐ฅ๐ฅ๐ฒ?
Since the Covid-19 outbreak, clinical research in tissue engineering is temporarily suspended and the funds are redirected for clinical trials for the Covid-19 vaccine. Moreover, several biotech and pharmaceutical companies have shifted the focus on finding drugs for Covid-19.
There is a significant reduction in cell and tissue donation programs since the Covid-19 outbreak.
Disruptions and delay in clinical research have affected tissue replacement and reconstructive surgeries.
๐๐ซ๐จ๐๐ฎ๐ซ๐ ๐๐จ๐ฆ๐ฉ๐ฅ๐๐ญ๐ ๐๐๐ฉ๐จ๐ซ๐ญ (๐๐๐ ๐๐๐ ๐๐ฌ ๐๐๐ ๐ฐ๐ข๐ญ๐ก ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐๐ก๐๐ซ๐ญ๐ฌ, ๐๐๐๐ฅ๐๐ฌ, ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ) @ https://www.alliedmarketresearch.com/checkout-final/f2db485871e8cac437db1d8144642789
The global tissue engineering market is segmented on the basis of type, application, and geography. Based on type, the market is divided into synthetic scaffold material, biologically derived scaffold material, and others. The biologically derived scaffold material segment dominated the market in 2019, accounting for more than half of the market. However, the synthetic scaffold material segment is expected to manifest the highest CAGR of 16.2% during the forecast period.
The market is categorized into orthopedics & musculoskeletal, neurology, cardiovascular, skin & integumentary, dental, and others. The orthopedics and musculoskeletal segment held the largest share in 2019, accounting for more than one-third of the market. However, the cardiovascular segment is expected to portray the highest CAGR of 17.4% during the forecast period.
๐ ๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ ๐๐ญ: https://www.alliedmarketresearch.com/purchase-enquiry/4323
The global tissue engineering market is analyzed across various regions such as North America, Europe, Asia-Pacific, and LAMEA. The market across North America held the lionโs share in 2019, contributing to nearly half of the market. However, the market across Asia-Pacific is estimated to register the highest CAGR of 16.3% during the forecast period.
The global tissue engineering market report includes an in-depth analysis of the major market players such as B. Braun Melsungen AG, AbbVie Inc. (Allergen Plc.), Integra LifeSciences, Becton, Dickinson and Company (C. R. BARD, INC.), Sid Martin Biotech (Axogen), Organogenesis Holdings, TissueTech Inc., Smith & Nephew Plc. (Osiris Therapeutics), Zimmer Biomet Holdings, Inc., and Vericel Corporation.
๐๐๐ฒ ๐ ๐ข๐ง๐๐ข๐ง๐ ๐ฌ ๐๐ ๐๐ก๐ ๐๐ญ๐ฎ๐๐ฒ:
By type, the biologically derived scaffold material segment dominated the global tissue engineering market in 2019.
On the basis of application, the orthopedics & musculoskeletal segment held largest tissue engineering market share in 2019, and is expected to remain dominant throughout the forecast period.
By region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 16.3% during the forecast period.
๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐ข๐ง ๐๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ:
Gene Synthesis Market: https://www.alliedmarketresearch.com/gene-synthesis-market-A39015
Mobile Tomography Market: https://www.alliedmarketresearch.com/mobile-tomography-market-A31901
Plasma Fractionation Market: https://www.alliedmarketresearch.com/plasma-fractionation-market
Influenza Vaccine Market: https://www.alliedmarketresearch.com/influenza-vaccines-market
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
๐๐จ๐ง๐ญ๐๐๐ญ:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
David Correa
Allied Analytics LLP
+ 1-800-792-5285
email us here